These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 26960322

  • 1. Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.
    Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Rafati S.
    Appl Microbiol Biotechnol; 2016 Aug; 100(16):7051-60. PubMed ID: 26960322
    [Abstract] [Full Text] [Related]

  • 2. Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model.
    Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Badirzadeh A, Rafati S.
    Parasite Immunol; 2016 Oct; 38(10):599-608. PubMed ID: 27213964
    [Abstract] [Full Text] [Related]

  • 3. Effects of Amphotericin B-Conjugated Functionalized Carbon Nanoparticles in the Treatment of Cutaneous Leishmaniasis.
    Heidari-Kharaji M, Guerra SS, Puneiad RP.
    Parasite Immunol; 2024 Oct; 46(10):e13068. PubMed ID: 39363635
    [Abstract] [Full Text] [Related]

  • 4. Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica.
    Kharaji MH, Doroud D, Taheri T, Rafati S.
    AAPS PharmSciTech; 2016 Oct; 17(5):1110-9. PubMed ID: 26552399
    [Abstract] [Full Text] [Related]

  • 5. Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
    Fernandes AP, Carvalho FA, Tavares CA, Santiago HC, Castro GA, Tafuri WL, Ferreira LA, Gazzinelli RT.
    J Infect Dis; 2001 Jun 01; 183(11):1646-52. PubMed ID: 11343214
    [Abstract] [Full Text] [Related]

  • 6. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
    Afzal I, Sarwar HS, Sohail MF, Varikuti S, Jahan S, Akhtar S, Yasinzai M, Satoskar AR, Shahnaz G.
    Nanomedicine (Lond); 2019 Feb 01; 14(4):387-406. PubMed ID: 30688557
    [Abstract] [Full Text] [Related]

  • 7. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
    Badirzadeh A, Heidari-Kharaji M, Fallah-Omrani V, Dabiri H, Araghi A, Salimi Chirani A.
    PLoS Negl Trop Dis; 2020 Jan 01; 14(1):e0007843. PubMed ID: 31929528
    [Abstract] [Full Text] [Related]

  • 8. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N, Chakraborty S, De AK, Ghosh S, Bera T.
    Eur J Pharm Sci; 2017 Jun 15; 104():196-211. PubMed ID: 28400285
    [Abstract] [Full Text] [Related]

  • 9. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES, Allahverdiyev AM, Bagirova M, Rafailovich M.
    Acta Trop; 2017 May 15; 169():30-42. PubMed ID: 28111133
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
    Wijnant GJ, Van Bocxlaer K, Yardley V, Murdan S, Croft SL.
    Antimicrob Agents Chemother; 2017 Aug 15; 61(8):. PubMed ID: 28607026
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle.
    Noormehr H, Zavaran Hosseini A, Soudi S, Beyzay F.
    Int Immunopharmacol; 2018 Jun 15; 59():97-105. PubMed ID: 29649772
    [Abstract] [Full Text] [Related]

  • 12. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A, Joseph M, Feltis T, Morris SK.
    Am J Trop Med Hyg; 2016 Oct 05; 95(4):793-794. PubMed ID: 27549634
    [Abstract] [Full Text] [Related]

  • 13. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E, Belkaid Y, Nguyen B, Wilson M, Sacks DL, Udey MC.
    J Invest Dermatol; 2002 Sep 05; 119(3):621-8. PubMed ID: 12230504
    [Abstract] [Full Text] [Related]

  • 14. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J, Moreno E, Calvo A, Blanco L, Fernández-Rubio C, Sanmartín C, Nguewa P, Irache JM, Larrea E, Espuelas S.
    J Dermatol Sci; 2018 Oct 05; 92(1):78-88. PubMed ID: 30037731
    [Abstract] [Full Text] [Related]

  • 15. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
    Abamor ES, Allahverdiyev AM.
    Exp Parasitol; 2016 Jul 05; 166():150-63. PubMed ID: 27109311
    [Abstract] [Full Text] [Related]

  • 16. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 05; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasis.
    Williams D, Mullen AB, Baillie AJ, Carter KC.
    J Pharm Pharmacol; 1998 Dec 05; 50(12):1351-6. PubMed ID: 10052848
    [Abstract] [Full Text] [Related]

  • 18. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S, Sinha S, Singh SK, Narayan S, Kumar V, Verma N, Ranjan A, Sinha PK, Das VN, Pandey K, Kar SK, Das P.
    Exp Parasitol; 2012 Jul 05; 131(3):274-82. PubMed ID: 22580024
    [Abstract] [Full Text] [Related]

  • 19. Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice.
    Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D.
    Exp Parasitol; 2011 Feb 05; 127(2):448-53. PubMed ID: 21035446
    [Abstract] [Full Text] [Related]

  • 20. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA, Marco JD, Calvopina M, Kato H, Korenaga M, Hashiguchi Y.
    J Antimicrob Chemother; 2007 Jun 05; 59(6):1123-9. PubMed ID: 17439977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.